Cited by 595Liver physiology and pathologyLiver Disease Diagnosis and TreatmentLiver Disease and Transplantation

The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.

Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets

Open access

Zhang, Chong-Yang, Yuan, Wei-Gang, He, Pei, Lei, Jia-Hui, Wang, Chun-Xu·2016·World Journal of Gastroenterology

DOI 10.3748/wjg.v22.i48.10512PMC PMC5192262

Open this paper in CoChat — free account Open PDF

Abstract

Liver fibrosis is a reversible wound-healing process aimed at maintaining organ integrity, and presents as the critical pre-stage of liver cirrhosis, which will eventually progress to hepatocellular carcinoma in the absence of liver transplantation.Fibrosis generally results from chronic hepatic injury caused by various factors, mainly viral infection, schistosomiasis, and alcoholism; however, the exact pathological mechanisms are still unknown.Although numerous drugs have been shown to have antifibrotic activity in vitro and in animal models, none of these drugs have been shown to be efficacious in the clinic.Importantly, hepatic stellate cells (HSCs) play a key role in the initiation, progression, and regression of liver fibrosis by secreting fibrogenic factors that encourage portal fibrocytes, fibroblasts, and bone marrow-derived myofibroblasts to produce collagen and thereby propagate fibrosis.These cells are subject to intricate cross-talk with adjacent cells, resulting in scarring and subsequent liver damage.Thus, an understanding of the molecular mechanisms of liver fibrosis and their relationships with HSCs is essential for the discovery of new therapeutic targets.This comprehensive review outlines the role of HSCs in liver fibrosis and details novel strategies to suppress HSC activity, thereby providing new insights into potential treatments for liver fibrosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.3748/wjg.v22.i48.10512

Cites

112 of 112 references verified0 citation errors · 0 not checkable

Statistics

Figure 1 Initiation, progression, and resolution of liver fibrosis involving hepatic stellate cells. Upon various types of chronic injury - including that caused by alcohol, viral and schistosome infection, nonalcoholic steatohepatitis (NASH), and other factors - hepatic stellate cells (HSCs) transdifferentiate from quiescent HSCs to activated HSCs, the latter of which secrete abundant extracellular proteins that contribute to liver fibrosis. Liver fibrosis is thought to be a reversible condition owing to the elimination of causative agents and different strategies of limiting HSC activation; however, they cannot totally return to a quiescent status of the naive HSCs. Instead, they exhibit a pre-activated intermediate condition with an increased sensitivity to injury. Thus, preventing recurrent chronic liver injury is of great importance in patients undergoing treatment for liver fibrosis. Untreated or relapsed fibrosis progresses to liver cirrhosis, which often requires hepatic transplantation.CC BY-NC · PubMed Central

Figure 2 Roles of interleukin-30, hydrogen peroxide inducible clone 5, and cholesterol acyltransferase 1 in liver fibrosis.CC BY-NC · PubMed Central

Figure 3 Roles of the Wnt, TGF-β/Smad, and Gas6/Axl signaling pathways in the progression of liver fibrosis.CC BY-NC · PubMed Central

Figure 4 Mechanism of action of three potential therapeutic drugs-ursolic acid, 24-nor-ursodeoxycholic acid, and resveratrol-for treating fibrosis.CC BY-NC · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
Vernon, G. C., Baranova, A. V., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,116
The burden of liver disease in Europe: A review of available epidemiological data
Blachier, M., Leleu, H., Peck‐Radosavljevic, M., Valla, D. C., & Roudot‐Thoraval, F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.005 · Cited by 1,340
The natural history of nonalcoholic fatty liver: A follow-up study
Teli, M. R., James, O., Burt, A. D., Bennett, M. K., & Day, C. P. (1995) · Hepatology · doi:10.1002/hep.1840220616 · Cited by 913
Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathway
Feldstein, A. E., Werneburg, N. W., Canbay, A. E., Guicciardi, M. E., Bronk, S. F., Rydzewski, R. M., Burgart, L. J., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20283 · Cited by 851
CYP2E1 and oxidative liver injury by alcohol
Lu, Y., & Cederbaum, A. I. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.11.004 · Cited by 805
Hepatic fibrosis: concept to treatment
Trautwein, C., Friedman, S. L., Schuppan, D., & Pinzani, M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.039 · Cited by 677
AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol
Um, J.-H., Park, S.-J., Kang, H., Yang, S., Foretz, M., McBurney, M. W., Kim, M. K., Viollet, B., & Chung, J. H. (2010) · Diabetes · doi:10.2337/db09-0482 · Cited by 647

Show all 112 references

Research works printed but not linked: 1

10.1002/cphy.c120035 · DOI · Paper page

Sorted by citations

Items 201–300 of 595

Suppressing circ_0008494 inhibits HSCs activation by regulating the miR-185-3p/Col1a1 axis
Li, B., Zhou, J., Luo, Y., Tao, K., Zhang, L., Zhao, Y., Lin, Y., Zeng, X. Y., & Yu, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1050093 · Cited by 22
Identification of hepatic fibrosis inhibitors through morphometry analysis of a hepatic multicellular spheroids model
Song, Y., Kim, S., Heo, J., Shum, D., Lee, S., Lee, M., Kim, A., & Seo, H. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-90263-x · Cited by 24
Early Diagnosis of Liver Injury and Real‐Time Evaluation of Photothermal Therapy Efficacy with a Viscosity‐Responsive NIR‐II Smart Molecule
Zan, Q., Fan, L., Lu, W., Zhang, Y., Huang, Y., Yu, X. Q., Han, Y., Zhang, R., Dong, C., & Shuang, S. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202402614 · Cited by 20
Recombinant truncated latency-associated peptide alleviates liver fibrosis in vitro and in vivo via inhibition of TGF-β/Smad pathway
Song, X., Shi, J., Liu, J., Liu, Y., Yu, Y., Qiu, Y., Cao, Z., Pan, Y., Yuan, X., Chu, Y., et al. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00508-2 · Cited by 22
IL-8 exacerbates CCl4-induced liver fibrosis in human IL-8-expressing mice via the PI3K/Akt/HIF-1α pathway
Ma, Y., Bao, Y., Wu, L., Ke, Y., Tan, L., Ren, H., Song, J., Zhang, Q. Y., & Jin, Y. J. (2022) · Molecular Immunology · doi:10.1016/j.molimm.2022.10.011 · Cited by 20
LY6D is crucial for lipid accumulation and inflammation in nonalcoholic fatty liver disease
Lee, J., Kim, H., Kang, Y.-W., Kim, Y., Park, M.-Y., Song, J., Jo, Y., Dao, T., Ryu, D., Lee, J., et al. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01033-w · Cited by 20
Mesenchymal stem cell-derived exosomal miR-26a induces ferroptosis, suppresses hepatic stellate cell activation, and ameliorates liver fibrosis by modulating SLC7A11
Cao, Y., Yang, H., Huang, Y., Lu, J., Du, H., & Wang, B. (2024) · Open Medicine · doi:10.1515/med-2024-0945 · Cited by 20
Noninvasive diagnostic tools for pediatric NAFLD: where are we now?
Mosca, A., Panera, N., Crudele, A., & Alisi, A. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2020.1801413 · Cited by 23
LncRNA MEG3 reverses CCl4-induced liver fibrosis by targeting NLRC5
Wu, Y., Wu, S., Li, X., Luo, S., Wang, A., Yin, S.-Q., Huang, C., & Li, J. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174462 · Cited by 20
MicroRNA-497 induced by Clonorchis sinensis enhances the TGF-β/Smad signaling pathway to promote hepatic fibrosis by targeting Smad7
Zhou, Q.-Y., Yang, H.-M., Liu, J.-X., Xu, N., Li, J., Shen, L., Zhang, Y., Koda, S., Zhang, B., Yu, Q., et al. (2021) · Parasites & Vectors · doi:10.1186/s13071-021-04972-3 · Cited by 20
Beyond M1/M2: The role of reactive oxygen species in liver fibrosis and immune modulation
Lu, H., Huang, J., Wang, Y.-C., Casals, E., Casals, G., & Zeng, M. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103933 · Cited by 19
AI‐Assisted Drug Re‐Purposing for Human Liver Fibrosis
Guan, Y., Cui, L., Inchai, J., Fang, Z., Law, J., Brito, A. A. G., Pawlosky, A., Gottweis, J., Daryin, A., Myaskovsky, A., et al. (2025) · Advanced Science · doi:10.1002/advs.202508751 · Cited by 25
Depletion of Bone Marrow-Derived Fibrocytes Attenuates TAA-Induced Liver Fibrosis in Mice
Hempel, F., Roderfeld, M., Savai, R., Sydykov, A. S., Irungbam, K., SCHERMULY, R. T., Voswinckel, R., Köhler, K., Churin, Y., Kiss, L., et al. (2019) · Cells · doi:10.3390/cells8101210 · Cited by 19
Amygdalin Ameliorates Liver Fibrosis through Inhibiting Activation of TGF-β/Smad Signaling
Xiao, Z., Ji, Q., Fu, Y., Gao, S., Hu, Y., Liu, W., Chen, G., Mu, Y., Chen, J., & Liu, P. (2021) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-021-3304-y · Cited by 19
Research Progress Regarding the Effect and Mechanism of Dietary Polyphenols in Liver Fibrosis
Chang, J., Huang, C., Li, S., Jiang, X., Chang, H., & Li, M. (2023) · Molecules · doi:10.3390/molecules29010127 · Cited by 20
Identification of Disulfidptosis-Related Genes in Ischemic Stroke by Combining Single-Cell Sequencing, Machine Learning Algorithms, and In Vitro Experiments
Zhao, S., Zhuang, H., Ji, W., Cheng, C., & Liu, Y. (2024) · NeuroMolecular Medicine · doi:10.1007/s12017-024-08804-2 · Cited by 19
Experimental Models to Investigate PNPLA3 in Liver Steatosis
Ramandi, A., Diehl, A., Sanyal, A. J., & de Jong, Y. P. (2025) · Liver International · doi:10.1111/liv.70091 · Cited by 19
Plantamajoside exerts antifibrosis effects in the liver by inhibiting hepatic stellate cell activation
Wang, Y., & Yan, D. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7843 · Cited by 19
Cell release during perfusion reflects cold ischemic injury in rat livers
de Vries, R. J., Pendexter, C. A., Cronin, S. E. J., Marques, B., Hafiz, E. O. A., Muzikansky, A., van Gulik, T. M., Markmann, J. F., Stott, S. L., Yeh, H., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-57589-4 · Cited by 19
A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis
Booijink, R. S., Salgado-Polo, F., Jamieson, C., Anastassis Perrakis, A., & Bansal, R. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202216333 · Cited by 20
Heparan Sulfate Proteoglycans (HSPGs) and Their Degradation in Health and Disease
Greco, N. M., Masola, V., & Onisto, M. (2025) · Biomolecules · doi:10.3390/biom15111597 · Cited by 20
Basic Principles of Liver Physiology
Casotti, V., & D’Antiga, L. (2019) · Springer eBooks · doi:10.1007/978-3-319-96400-3_2 · Cited by 18
Antifibrotic effect of curcumin, N-acetyl cysteine and propolis extract against bisphenol A-induced hepatotoxicity in rats: Prophylaxis versus co-treatment
El-Swefy, S. E., Abdallah, F. R., Wahba, A. S., Hasan, R. A., & Atteia, H. H. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118245 · Cited by 18
Perfluorooctane sulfonate aggravates CCl4 ‐induced hepatic fibrosis via HMGB1 / TLR4 /Smad signaling
Wan, C., Gu, T., Ling, J., Qin, Y., Luo, J., Sun, L., Hua, L., Zhao, J., & Jiang, S. (2022) · Environmental Toxicology · doi:10.1002/tox.23458 · Cited by 17
Vitamin A - modified Betulin polymer micelles with hepatic targeting capability for hepatic fibrosis protection
Liu, X., Li, D., Li, T. Y., Wu, Y., Piao, J. S., & Piao, M. G. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106189 · Cited by 18
Crosstalk Between Autophagy and Innate Immunity: A Pivotal Role in Hepatic Fibrosis
Chen, L., Kong, D., Xia, S., Wang, F., Li, Z., Zhang, F., & Zheng, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.891069 · Cited by 18
Emerging roles of non-coding RNAs in fibroblast to myofibroblast transition and fibrotic diseases
Xing, X., & Rodeo, S. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1423045 · Cited by 18
MicroRNA-744/transforming growth factor β1 relationship regulates liver cirrhosis
Ren, S., Chen, J., Wang, Q., Li, X., Xu, Y., Zhang, X., Mu, Y., Zhang, H., Huang, S., & Liu, P. (2019) · Hepatology International · doi:10.1007/s12072-019-09993-w · Cited by 18
Lysosomal acid lipase is the major acid retinyl ester hydrolase in cultured human hepatic stellate cells but not essential for retinyl ester degradation
Wagner, C., Hois, V., Pajed, L., Pusch, L.-M., Wolinski, H., Trauner, M. A., Zimmermann, R., Taschler, U., & Lass, A. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158730 · Cited by 18
Recent Advances: The Imbalance of Immune Cells and Cytokines in the Pathogenesis of Hepatocellular Carcinoma
Jayant, K., Habib, N., Huang, K., Warwick, J., & Arasaradnam, R. P. (2020) · Diagnostics · doi:10.3390/diagnostics10050338 · Cited by 18
BAY 41-2272 Attenuates CTGF Expression via sGC/cGMP-Independent Pathway in TGFβ1-Activated Hepatic Stellate Cells
Chen, P., Kuo, L.-M., Wu, Y.-H., Chang, Y., Lai, K.-H., & Hwang, T. (2020) · Biomedicines · doi:10.3390/biomedicines8090330 · Cited by 18
Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study
Kronborg, T. M., Ytting, H., Hobolth, L., Møller, S., & Kimer, N. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.718896 · Cited by 18
Multi‐faceted role of pyroptosis mediated by inflammasome in liver fibrosis
Yang, H., Wang, J., & Liu, Z. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17277 · Cited by 17
The T Cell Receptor Immune Repertoire Protects the Liver From Reconsitution
Liang, Q. D., Hu, Y., Zhang, M., Lin, C., Zhang, W., Li, Y., Zhu, P., Xue, P., Chen, Y., Li, Q., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.584979 · Cited by 16
Extracellular Vesicular Transmission of miR-423-5p from HepG2 Cells Inhibits the Differentiation of Hepatic Stellate Cells
Safran, M., Masoud, R., Sultan, M., Tachlytski, I., Gadot, C. C., Pery, R., Balint‐Lahat, N., Pappo, O., Buzaglo, N., & Ben‐Ari, Z. (2022) · Cells · doi:10.3390/cells11101715 · Cited by 17
Small extracellular vesicles encapsulating lefty1 mRNA inhibit hepatic fibrosis
Zhao, Y., Yu, Y., Wang, S., Li, J., & Teng, L. (2022) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2022.07.004 · Cited by 17
Hydroxysafflor yellow A exerts anti-fibrotic and anti-angiogenic effects through miR-29a-3p/PDGFRB axis in liver fibrosis
Xue, X., Li, Y., Zhang, S., Yao, Y., Peng, C. Y., & Li, Y. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155830 · Cited by 17
Determination of selenium during pathogenesis of hepatic fibrosis employing hydride generation and inductively coupled plasma mass spectrometry
George, J. (2018) · Biological Chemistry · doi:10.1515/hsz-2017-0260 · Cited by 17
Study on the association between TGF‑β1 and liver fibrosis in patients with hepatic cystic echinococcosis
Tian, F., Liu, Y., Gao, J. P., Yang, N., Shang, X., Lv, J., Ba, D., Zhou, X., Zhang, C., & Ma, X. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8355 · Cited by 17
Self-citation
Formyl Peptide Receptor 2 Alleviates Hepatic Fibrosis in Liver Cirrhosis by Vascular Remodeling
Jun, J. H., Park, S. Y., Park, S., Park, H. J., Kim, J. Y., Park, G. T., Bae, S. H., Kim, J. H., & Kim, G. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042107 · Cited by 17
Protective effect of Idelalisib on carbon tetrachloride‐induced liver fibrosis via microRNA‐124‐3P/phosphatidylinositol‐3‐hydroxykinase signalling pathway
Li, X., Li, H., Zhang, S., Zhang, R., Li, J., Wei, Y., Yang, C., Zhang, F., & Zhou, H. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17039 · Cited by 15
Nanomaterial Manipulation of Immune Microenvironment in the Diseased Liver
Hu, M., & Huang, L. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201805760 · Cited by 17
Matrix metalloproteinase-8 (MMP-8) regulates the activation of hepatic stellate cells (HSCs) through the ERK-mediated pathway
Naim, A., & Baig, M. S. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03705-x · Cited by 15
Anti-fibrotic effects of brevilin A in hepatic fibrosis via inhibiting the STAT3 signaling pathway
Park, Y. J., Jeon, M. S., Lee, S., Kim, J. K., Jang, T. S., Chung, K. H., & Kim, K. H. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.127989 · Cited by 16
Tanshinone IIA regulates the TGF‑β1/Smad signaling pathway to ameliorate non‑alcoholic steatohepatitis‑related fibrosis
Xu, L., Zhang, Y., Ji, N., Du, Y., Jia, T., Wei, S., Wang, W., Zhang, S., & Chen, W. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11413 · Cited by 16
CD73-Adenosine A1R Axis Regulates the Activation and Apoptosis of Hepatic Stellate Cells Through the PLC-IP3-Ca2+/DAG-PKC Signaling Pathway
Liu, Z., Wu, X., Wang, Q., Li, Z., Liu, X., Sheng, X., Zhu, H., Zhang, M., Xu, J., Feng, X., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.922885 · Cited by 16
Mulberroside A ameliorates CCl4‐induced liver fibrosis in mice via inhibiting pro‐inflammatory response
Shi, B., Qian, J., Miao, H., Zhang, S., Hu, Y., Liu, P., & Xu, L. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3333 · Cited by 16
A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression
Ramezani, M., Zobeiry, M., Abdolahi, S., Hatami, B., Zali, M. R., & Baghaei, K. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154809 · Cited by 16
Dapagliflozin dampens liver fibrosis induced by common bile duct ligation in rats associated with the augmentation of the hepatic Sirt1/AMPK/PGC1α/FoxO1 axis
Hassan, H. A., Nageeb, M. M., Mohammed, H. O., Samy, W. M., Fawzy, A., Afifi, R., & Abbas, N. A. T. (2024) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2024.116991 · Cited by 17
Cryptotanshinone alleviates liver fibrosis via inhibiting STAT3/CPT1A-dependent fatty acid oxidation in hepatic stellate cells
Li, Z., Zheng, Y., Zhang, L., & Xu, E. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.111119 · Cited by 16
2-Methoxyestradiol attenuates liver fibrosis in mice: implications for M2 macrophages
Neamatallah, T., Abdel‐Naim, A. B., Eid, B. G., & Hasan, A. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1577-2 · Cited by 16
Effect of NLRC5 on activation and reversion of hepatic stellate cells by regulating the nuclear factor-κB signaling pathway
Zhang, Y.-Z., Yao, J., Zhang, L., Wang, C., Zhang, X., & Gao, B. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i24.3044 · Cited by 16
Self-citation
lncRNA MEG3 modulates hepatic stellate cell activation by sponging miR‑145 to regulate PPARγ
Qin, R., Huang, W., Huang, Y., Zhang, Z., Su, Y., Chen, S., & Wang, H. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12519 · Cited by 16
Diagnosis of liver fibrosis and liver function reserve through non-invasive multispectral photoacoustic imaging
Qiu, T., Yang, J., Peng, C., Xiang, H., Huang, L., Ling, W., & Luo, Y. (2023) · Photoacoustics · doi:10.1016/j.pacs.2023.100562 · Cited by 15
Insulin receptor responsiveness governs TGFβ ‐induced hepatic stellate cell activation: Insulin resistance instigates liver fibrosis
Lee, W., Bates, E. A., Kipp, Z. A., Pauss, S. N., Martinez, G. J., Blair, C. A., & Hinds, T. D. (2025) · The FASEB Journal · doi:10.1096/fj.202402169r · Cited by 15
Detection of Novel Biomarkers in Pediatric Autoimmune Hepatitis by Proteomic Profiling
Sîrbe, C., Badii, M. O., Crișan, T. O., Bența, G., Grama, A., Joosten, L. A. B., Rednic, S., & Pop, T. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087479 · Cited by 16
The role of lncRNA-mediated ceRNA regulatory networks in liver fibrosis
Jiang, J., Фанилевич, Г. И., Ilyasova, T., Shumadalova, A. V., Du, W., & Yang, B. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.01.001 · Cited by 15
Dual Roles of microRNA-122 in Hepatocellular Carcinoma and Breast Cancer Progression and Metastasis: A Comprehensive Review
Ageeli, E. A. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46110711 · Cited by 17
Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts via activation of the Hedgehog signaling pathway
Pan, X.-R., Jing, Y.-Y., Liu, W.-T., Han, Z.-P., Li, R., Yang, Y., Zhu, J.-N., Li, X.-Y., Li, P.-P., & Wei, L.-X. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1325976 · Cited by 15
Astaxanthin inhibits proliferation and induces apoptosis of LX‑2 cells by regulating the miR‑29b/Bcl‑2 pathway
Zhu, S., Wang, T., Luo, F., Li, H., Jia, Q., He, T., Wu, H., & Zou, T. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10025 · Cited by 15
A triterpenoid-enriched extract of bitter melon leaves alleviates hepatic fibrosis by inhibiting inflammatory responses in carbon tetrachloride-treated mice
Chang, M.-L., Lin, Y.-T., Kung, H., Hou, Y.-C., Liu, J., Pan, M., Chen, H., Yu, C.-H., & Tsai, P. (2021) · Food & Function · doi:10.1039/d1fo00884f · Cited by 15
Perilipin 5 Ameliorates Hepatic Stellate Cell Activation via SMAD2/3 and SNAIL Signaling Pathways and Suppresses STAT3 Activation
Cierpka, R., Weiskirchen, R., & Asimakopoulos, A. (2021) · Cells · doi:10.3390/cells10092184 · Cited by 15
The Roles and Mechanisms of lncRNAs in Liver Fibrosis
Wang, Z., Yang, X., Gui, S., Yang, F., Cao, Z., Cheng, R., Xia, X., & Li, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.779606 · Cited by 19
Asiatic acid alleviates liver fibrosis via multiple signaling pathways based on integrated network pharmacology and lipidomics
Li, Y., He, X.-L., Zhou, L., Huang, X.-Z., Li, S., Guan, S., Li, J., & Zhang, L. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175193 · Cited by 15
Anti-tumor activity of KNTC2 siRNA in orthotopic tumor model mice of hepatocellular carcinoma
Makita, Y., Murata, S., Katou, Y., Kikuchi, K., Uejima, H., Teratani, M., Hoashi, Y., Kenjo, E., Matsumoto, S., Nogami, M., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.088 · Cited by 15
Tripartite motif protein 52 (TRIM52) promoted fibrosis in LX‐2 cells through PPM1A‐mediated Smad2/3 pathway
Zhou, J., Lan, Q., Li, W., Yang, L., You, J., Zhang, Y., & Ni, W. (2019) · Cell Biology International · doi:10.1002/cbin.11206 · Cited by 15
Cryptotanshinone induces apoptosis of activated hepatic stellate cells via modulating endoplasmic reticulum stress
Hou, X.-X., Li, Y., Song, J., Zhang, W., Liu, R. R., Yuan, H., Feng, T.-T., Jiang, Z.-Y., Li, W., & Zhu, C. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i17.2616 · Cited by 14
Overview of CircRNAs Roles and Mechanisms in Liver Fibrosis
Wang, G., Tong, J., Li, Y.-C., Qiu, X., Chen, A., Chang, C., & Yu, G. (2023) · Biomolecules · doi:10.3390/biom13060940 · Cited by 14
Hepatobiliary organoids differentiated from hiPSCs relieve cholestasis-induced liver fibrosis in nonhuman primates
Li, H., Li, J., Wang, T., Sun, K., Huang, G., Cao, Y., Wu, F., & Xu, A. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.90441 · Cited by 15
Resveratrol Alleviates Arsenic Exposure-Induced Liver Fibrosis in Rats by Inhibiting Hepatocyte Senescence
Ran, Q., Song, D., Wang, Q., Wang, D., Chen, X., Zhang, A., & Ma, L. (2024) · Biological Trace Element Research · doi:10.1007/s12011-024-04255-9 · Cited by 14
Fibroblast Growth Factor–21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells
Opoku, Y. K., Liu, Z., Afrifa, J., Kumi, A. K., Liu, H., Ghartey‐Kwansah, G., Koranteng, H., Jiang, X., Ren, G., & Li, D. (2020) · EXCLI journal · doi:10.17179/excli2020-1287 · Cited by 14
Elevation of microRNA-214 is associated with progression of liver fibrosis in patients with biliary atresia
Yoneyama, T., Ueno, T., Masahata, K., Toyama, C., Maeda, A., Tazuke, Y., Oue, T., Miyagawa, S., & Okuyama, H. (2021) · Pediatric Surgery International · doi:10.1007/s00383-021-05009-7 · Cited by 14
Dendropanoxide, a Triterpenoid from Dendropanax morbifera, Ameliorates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells through Autophagy Inhibition
Park, Y.-J., Kim, D., Choi, H.-B., Jeong, M. H., Kwon, S., Kim, H.-R., Kwak, J. H., & Chung, K. (2021) · Nutrients · doi:10.3390/nu14010098 · Cited by 14
Rat bone marrow mesenchymal stem cells (BMSCs) inhibit liver fibrosis by activating GSK3β and inhibiting the Wnt3a/β-catenin pathway
Liu, Z., Zhou, S., Zhang, Y., & Zhao, M. (2022) · Infectious Agents and Cancer · doi:10.1186/s13027-022-00432-4 · Cited by 14
Identification of Liver Fibrosis-Related MicroRNAs in Human Primary Hepatic Stellate Cells Using High-Throughput Sequencing
Liu, X., Ma, H., Wu, R., Wang, H., Xu, H., Li, S., Wang, G., Lv, G., & Niu, J. (2022) · Genes · doi:10.3390/genes13122201 · Cited by 14
Acanthoic acid protectsagainst ethanol-induced liver injury: Possible role of AMPK activation and IRAK4 inhibition
Yao, Y., Han, X., Song, J., Zhang, J., Li, Y., Lian, L., Wu, Y., & Nan, J. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.09.020 · Cited by 14
The Role of Stem Cell Factor, Epidermal Growth Factor and Angiopoietin-2 in HBV, HCV, HCC and NAFLD
Radmanić, L., & Lepej, S. Ž. (2022) · Life · doi:10.3390/life12122072 · Cited by 14
GL-V9 ameliorates liver fibrosis by inhibiting TGF-β/smad pathway
Guo, Y., Geng, T., Chen, X., Hou, Y., Zhang, X., Xue, X., Zhao, L., & Wu, Y. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113521 · Cited by 13
Mitochondrial-mediated nuclear remodeling and macrophage polarizations: A key switch from liver fibrosis to HCC progression
Verma, S., Ishteyaque, S., Washimkar, K. R., Verma, S., & Mugale, M. N. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113878 · Cited by 13
Engineered lipid nanoparticles enable therapeutic gene silencing of GTSE1 for the treatment of liver fibrosis
Jeong, M., Shin, S., Lee, G., Lee, Y., Park, S. B., Kang, J., Lee, Y., Seo, W., & Lee, H. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.08.012 · Cited by 15
Cirrhosis induced by thioacetamide is prevented by stevia. Molecular mechanisms
Ramos‐Tovar, E., Casas‐Grajales, S., Hernández‐Aquino, E., Flores‐Beltrán, R. E., Galindo‐Gómez, S., Vera‐Aguilar, E., Dı́az-Ruiz, A., Montes, S., Camacho, J., Tsutsumi, V., et al. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.11.039 · Cited by 13
Tyrosine kinase inhibitor neratinib attenuates liver fibrosis by targeting activated hepatic stellate cells
Park, Y. J., An, H.-T., Park, J. S., Park, O., Duh, A. J., Kim, K., Chung, K. H., Lee, K. C., Oh, Y., & Lee, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-71688-2 · Cited by 15
Functional Inhibition of Natural Killer Cells in a BALB/c Mouse Model of Liver Fibrosis Induced by Schistosoma japonicum Infection
Hu, Y., Wang, X., Wei, Y., Liu, H., Zhang, J., Shen, Y., & Cao, J. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.598987 · Cited by 14
Antifibrotic and anthelminthic effect of casticin on Schistosoma mansoni-infected BALB/c mice
Lam, H. Y. P., Liang, T.-R., Lan, Y.-C., Chang, K., Cheng, P.-C., & Peng, S.-Y. (2021) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2021.03.017 · Cited by 13
Fibronectin-targeted FUD and PEGylated FUD peptides for fibrotic diseases
Lee, H. J., Tomasini-Johansson, B. R., Gupta, N., & Kwon, G. S. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.06.008 · Cited by 14
Hydrocortisone Suppresses Early Paraneoplastic Inflammation And Angiogenesis To Attenuate Early Hepatocellular Carcinoma Progression In Rats
Liu, X., Cui, H., Niu, H., Wang, L., Li, X., Sun, J., Wei, Q., Dong, J., Liu, L., & Xian, C. J. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s224618 · Cited by 13
Comparison between galectin-3 and YKL-40 levels for the assessment of liver fibrosis in cirrhotic patients
Turco, S. D., SIMONE, P. D., Ghinolfi, D., Gaggini, M., & Basta, G. (2021) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2021.03.002 · Cited by 13
Advancements in the understanding of mechanisms of the IL-6 family in relation to metabolic-associated fatty liver disease
Liu, J., Wang, T., Yang, F., & Pubu, C. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1642436 · Cited by 13
The roles of ETS transcription factors in liver fibrosis
Zhang, L.-Y., Tan, Y., Luo, X., Wu, J., & Ni, Y. (2022) · Human Cell · doi:10.1007/s13577-022-00848-5 · Cited by 11
Inhibitory effects of Curcumae Radix carbonisata -based carbon dots against liver fibrosis induced by carbon tetrachloride in mice
Zhao, Y., Kong, H., Li, Y., Zhao, Y., Zhang, Y., Zhao, Y., & Qu, H. (2023) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2023.2239522 · Cited by 12
Linking fatty liver diseases to hepatocellular carcinoma by hepatic stellate cells
Chen, L., Ye, X.-S., Yang, L., Zhao, J., You, J., & Feng, Y. (2024) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2024.01.002 · Cited by 12
Salvianolic acid B in fibrosis treatment: a comprehensive review
Liang, Q., Liu, X., Peng, X., Luo, T., Su, Y. R., Xu, X., Xie, H., Gao, H. C., Chen, Z., & Xie, C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1442181 · Cited by 13
Visium spatial transcriptomics and proteomics identifies novel hepatic cell populations and transcriptomic signatures of alcohol‐associated hepatitis
Gripshover, T. C., Treves, R. S., Rouchka, E. C., Chariker, J. H., Zheng, S., Hudson, E., Smith, M. L., Singal, A. K., McClain, C. J., & Hardesty, J. (2024) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15494 · Cited by 12
Can Schistosoma japonicum infection cause liver cancer?
Jain, S. (2025) · Journal of Helminthology · doi:10.1017/s0022149x24000762 · Cited by 12
The role of let-7b in the inhibition of hepatic stellate cell activation by rSjP40
Sun, X., Zhang, L., Jiang, Y., Li, A., Zhu, D., Wu, J., & Duan, Y. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009472 · Cited by 12
Protective effects of isoflavones on alcoholic liver diseases: Computational approaches to investigate the inhibition of ALDH2 with isoflavone analogues
Lee, W., & Kim, S.-J. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1147301 · Cited by 12
Anthocyanins improve liver fibrosis in mice by regulating the autophagic flux level of hepatic stellate cells by mmu_circ_0000623
Du, J., Liu, L., Fan, H., Yu, Y., Luo, Y., Gu, F., Yu, H., & Liao, X. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3281 · Cited by 12
Downregulation of miR‑152 contributes to the progression of liver fibrosis via targeting Gli3 in�vivo and in�vitro
Li, L., Zhang, L., Zhao, X., Cao, J. W., Li, J., & Chu, G. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7595 · Cited by 12
Targeting the eicosanoid pathway in hepatocellular carcinoma.
Razdan, A., Main, N., Chiu, V., Shackel, N. A., SOUZA, P. D., Bryant, K., & Scott, K. F. (2021) · PubMed Central · Cited by 13
A bibliometric and visualized analysis of liver fibrosis from 2002 to 2022
Zhao, Q., Liang, L., Zhai, F., Ling, G., Xiang, R., & Jiang, X. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16081 · Cited by 12

Authors: Zhang, C.-Y., Yuan, W.-G., He, P., Lei, J.-H., & Wang, C.-X.
Affiliations: Huazhong University of Science and Technology (CN)
Venue: World Journal of Gastroenterology
Publisher: Baishideng Publishing Group Inc.
Published: 2016
Volume: 22
Issue: 48
Pages: 10512
ISSN: 1007-9327 (ISSN-L)
DOI: 10.3748/wjg.v22.i48.10512
PMC: PMC5192262
OpenAlex: W2565367159
Cited by: 594
References: 112
Citations by year: 2026: 37 · 2025: 70 · 2024: 75 · 2023: 80 · 2022: 84 · 2021: 88 · 2020: 60 · 2019: 59 · 2018: 24 · 2017: 15
FWCI: 4.07
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc
Locations: World Journal of Gastroenterology (publishedVersion, cc-by-nc)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion, cc-by-nc)
PubMed (publishedVersion)
Funders: National Natural Science Foundation of China (81300251)
Topics: Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords: liver fibrosis, hepatic stellate cells, liver cirrhosis, hepatocellular carcinoma, antifibrotic therapy, fibrogenic factors, collagen synthesis, myofibroblasts, viral hepatitis, schistosomiasis, alcoholic liver disease, cell-cell crosstalk, therapeutic target
MeSH terms: Resveratrol, Ursolic Acid, Acetyl-CoA C-Acetyltransferase, Animals, Fatty Liver, Alcoholic, Humans, Interleukins, Liver Cirrhosis, Macrophages, Schistosomiasis, Stilbenes, Triterpenes, Ursodeoxycholic Acid, Virus Diseases, Signal Transduction, CD4-Positive T-Lymphocytes, Disease Progression, MicroRNAs, Intracellular Signaling Peptides and Proteins, T-Lymphocytes, Regulatory, Hepatic Stellate Cells, Molecular Targeted Therapy, LIM Domain Proteins, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks